The Critical Role of Pharmacists in Management and Adherence of Glaucoma Therapy

Pharmacy Times, February 2015 Autoimmune Disorders, Volume 81, Issue 2

This continuing education activity is supported by an unrestricted educational grant from Alcon, Inc.

This activity is supported by an unrestricted educational grant from Alcon, Inc.

The Critical Role of Pharmacists in Management and Adherence of Glaucoma Therapy

Faculty

Jamie Rickards, PharmD, MBA, BCPS

Assistant Professor

Clinical & Administrative Sciences

Notre Dame of Maryland University

School of Pharmacy

Baltimore, Maryland

Michelle A. Fritsch, PharmD, CGP, BCACP

Professor and Chair

Clinical & Administrative Sciences

Notre Dame of Maryland University

School of Pharmacy

Baltimore, Maryland

Educational Objectives

After participating in this activity, participants should be able to:

  • Demonstrate knowledge of the risk factors, pathophysiology, and etiology of the different types of glaucoma.
  • Define the mechanism of action as well as safety and efficacy profiles of the different treatment classes and individual agents available for the management of glaucoma.
  • Educate patients on proper administration and scheduling of their eye drops, as well as the importance of treatment adherence.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

January, 23, 2015

Expiration date:

January, 23, 2017

Estimated time to complete activity:

2.0 hours

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-011-H01-P. The activity is available for CE credit through January 28, 2017.